AGEN · Agenus Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 6.67 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 18 / 38 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 28 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -101.0% |
| Sales growth Q/Q | +13.1% |
| Distance from 52-week high | +32.8% |
| Market cap (USD) | $144.4M |